J. Behr (Munich, Germany), D. Israel-Biet (Paris, France)
Genetic association studies between the myd88 adaptor pathway SNPs and the development of sarcoidosis
Z. D. Daniil, V. Mollaki, F. Malli, A. Koutsokera, K. I. Gourgoulianis, G. Vassilopoulos (Larissa, Athens, Greece)
|   |
Genetic association analysis suggests overrepresentation of different pathways in lofgren‘s syndrome and sarcoidosis
C. H. M. van Moorsel, J. C. Grutters, H. J. Megens, M. Nagtegaal, M. Heron, V. L. J. Karthaus, R. van ‘t Slot, M. Bevova, A. H. van der Helm, T. W. Huizinga, H. J. T. Ruven, J. M. M. van den Bosch (Nieuwegein, Wageningen, Utrecht, Leiden, Netherlands)
| |
Pulmonary and extrapulmonary sarcoidosis immunophenotyping study
P. Da Silva, E. R. Parra, I. Narde, W. Zocolaro, V. Capelozzi (São Paulo, Brazil)
| |
Static lung compliance and DLCO often demonstrate parenchymal involvement in sarcoidosis despite a normal total lung capacity
P. Boros, M. Martusewicz-Boros, S. Wesolowski (Warsaw, Poland)
| |
Exercise evaluation in relation to pft in sarcoid patients
M. Bednarek, A. Goljan-Geremek, P. Boros, M. Kram, D. Gorecka (Warsaw, Poland)
| |
Unusual clinical presentations of biopsy proven sarcoidosis from North India
A. Singh, S. Jindal, D. Gupta, A. N. Aggarwal (Chandigarh, India)
| |
A case of sarcoidosis that cause endobronchial mass
S. Akpinar, N. Uçar, Z. Aktas, Y. Agaçkiran, T. Sipit (Ankara, Turkey)
| |
Short-term linear and nonlinear ("chaotic") characteristics of R-R interval dynamics in patients with sarcoidosis
E. Gialafos, A. Rapti, T. Papaioannou, A. Kalianos, G. Siasos, C. Saldari, G. Marinos, L. Velentsa, O. Anagnostopoulou, C. Kostopoulos, C. Stefanadis (Athens, Greece)
| |
Scottish pulmonary sarcoidosis – an exploratory analysis of prevalence, presentation and clinical data in nearly 200 patients
G. Laing, M. Moffat, J. Cleland, G. Christie, P. Fitch, E. Paterson, O. Dempsey (Aberdeen, United Kingdom)
| |
Infliximab for treating sarcoidosis, portuguese experience
M. Aguiar, M. Felizardo, N. Marçal, A. C. Mendes, A. Bugalho de Almeida (Lisboa, Portugal)
| |
Diagnostic value of high resolution computerised tomography in sarcoidosis
S. Kasikovic-Lecic, M. Stojanovic, M. Ilic, D. Kukavica, L. Vrtunski-More, G. Popovic (Sremska Kamenica, Republic Of Serbia)
| |
The sarcoidosis-tuberculosis (TB) link: molecular evidence from a high (TB) prevalence country
D. Gupta, V. K. Mootha, R. Agarwal, J. Ahmed, I. Verma (Chandigarh, India)
| |
Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment
E. Popov, G. Kaminskaya, R. Abdullaev, V. Romanov (Moscow, Russian Federation)
| |
Extrapulmonary sarcoidosis diagnostics
E. Vladimirova, V. Romanov, E. Shmelev (Moscow, Russian Federation)
| |
A case of subcutaneous sarcoidosis with a rare localisation
G. Celik, A. Ciledag, P. Akin, Y. Simsek, A. Kaya, N. Numanoglu, Y. Y. Saglik, A. Boyvat (Ankara, Turkey)
| |
Prevalence of thyroid disease and thyroid autoimmunity in sarcoidosis
F. Malli, A. Bargiota, I. Plisiotis, E. Zakynthinos, A. E. Germenis, K. I. Gourgoulianis, Z. D. Daniil (Larissa, Greece)
| |
Sarcoidosis – experience from south India
P. Rekha, P. Sukumaran, K. Venugopal, B. Thomas (Kottayam, India)
| |
The structure and dynamics of primary disablement because of sarcoidosis in Belarus
H. Baradzina (Minsk, Belarus)
| |
Exhaled 8-isoprostane as a possible prognostic marker in sarcoidosis
W. Piotrowski, Z. Kurmanowska, A. Antczak, J. Marczak, P. Górski (Lodz, Poland)
| |
YKL-40, soluble IL-2 receptor, ADA and neopterin: comparison of markers of sarcoidosis activity
R. Gelisgen, H. Uzun, E. C. Seyhan, O. Celik, G. Günlüoglu (Istanbul, Turkey)
| |